Andrew D'Silva
Stock Analyst at B. Riley Securities
(3.17)
# 1,156
Out of 4,749 analysts
28
Total ratings
61.54%
Success rate
91.04%
Average return
Main Sectors:
Stocks Rated by Andrew D'Silva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTRK Ontrak | Downgrades: Neutral | $1,350 | $1.68 | +80,257.14% | 2 | Aug 20, 2021 | |
| MPLN MultiPlan | Initiates: Buy | $400 | $18.26 | +2,090.58% | 1 | Apr 7, 2021 | |
| CYRX Cryoport | Maintains: Buy | $69 → $81 | $7.54 | +974.27% | 4 | Feb 10, 2021 | |
| GERN Geron | Maintains: Buy | $3.5 → $4 | $2.87 | +39.37% | 3 | May 29, 2020 | |
| CRMD CorMedix | Maintains: Buy | $10 → $12 | $10.27 | +16.85% | 3 | May 12, 2020 | |
| OPRX OptimizeRx | Maintains: Buy | $18 → $22 | $5.55 | +296.40% | 4 | May 5, 2020 | |
| EDAP EDAP TMS | Initiates: Buy | $5.5 | $2.44 | +125.41% | 1 | Apr 15, 2020 | |
| HROW Harrow | Maintains: Buy | $12 → $10 | $30.72 | -67.45% | 2 | Apr 7, 2020 | |
| EYPT EyePoint Pharmaceuticals | Downgrades: Neutral | $40 → $10 | $7.65 | +30.72% | 1 | Apr 6, 2020 | |
| CPIX Cumberland Pharmaceuticals | Maintains: Buy | $9 → $9.75 | $2.26 | +331.42% | 4 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $93 | $196.44 | -52.91% | 2 | Aug 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $2.24 | +792.86% | 1 | Dec 11, 2017 |
Ontrak
Aug 20, 2021
Downgrades: Neutral
Price Target: $1,350
Current: $1.68
Upside: +80,257.14%
MultiPlan
Apr 7, 2021
Initiates: Buy
Price Target: $400
Current: $18.26
Upside: +2,090.58%
Cryoport
Feb 10, 2021
Maintains: Buy
Price Target: $69 → $81
Current: $7.54
Upside: +974.27%
Geron
May 29, 2020
Maintains: Buy
Price Target: $3.5 → $4
Current: $2.87
Upside: +39.37%
CorMedix
May 12, 2020
Maintains: Buy
Price Target: $10 → $12
Current: $10.27
Upside: +16.85%
OptimizeRx
May 5, 2020
Maintains: Buy
Price Target: $18 → $22
Current: $5.55
Upside: +296.40%
EDAP TMS
Apr 15, 2020
Initiates: Buy
Price Target: $5.5
Current: $2.44
Upside: +125.41%
Harrow
Apr 7, 2020
Maintains: Buy
Price Target: $12 → $10
Current: $30.72
Upside: -67.45%
EyePoint Pharmaceuticals
Apr 6, 2020
Downgrades: Neutral
Price Target: $40 → $10
Current: $7.65
Upside: +30.72%
Cumberland Pharmaceuticals
Dec 3, 2019
Maintains: Buy
Price Target: $9 → $9.75
Current: $2.26
Upside: +331.42%
Aug 24, 2018
Maintains: Buy
Price Target: $81 → $93
Current: $196.44
Upside: -52.91%
Dec 11, 2017
Reinstates: Buy
Price Target: $20
Current: $2.24
Upside: +792.86%